Clinical Trial Update: HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HDS plus peripheral blood progenitor cell transplant to additional FrontLine therapy in patients with aggressive non-Hodgkin lymphoma wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: High-Grade Lymphomas | Phase 3 | Status: COMPLETED